BIOTECH & CRO

Ascentia is a biotechnology company and CRO partner focused on the discovery and development of small molecule compounds that target key pathological mechanisms underlying inflammatory, fibrotic, and neoplastic diseases. Our internal R&D projects are driven by a strong scientific focus on exploration of the therapeutic potential of under characterized transmembrane receptors.

As a contract research organization, we collaborate with biotech companies, pharmaceutical firms, and academic research groups—offering access to our integrated capabilities in medicinal chemistry, synthetic chemistry, molecular biology, and computational drug design. Whether supporting early discovery, optimizing lead compounds, or scaling complex syntheses, Ascentia delivers science-driven, flexible solutions tailored to your R&D goals.